Spatial Biology Market - A Global and Regional Analysis: Focus on Molecular Technology, Product Type, Sample Type, Application, and Regional Analysis - Analysis and Forecast, 2025-2035
The global spatial biology market is projected to reach $6,391.1 million by 2035 from $1,649.5 million in 2024, growing at a CAGR of 13.10% during the forecast period 2025-2035.
Biobanking Cold Storage Equipment Market - A Global and Regional Analysis: Focus on Offering, End User, and Region - Analysis and Forecast, 2024-2033
The global biobanking cold storage equipment market was valued at $1,500.9 million in 2024 and is anticipated to reach $2,889.9 million by 2033, witnessing a CAGR of 7.55% during the forecast period 2024-2033.
Epstein Barr Virus Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035
The global epstein barr virus market is highly competitive, with several key players driving innovation and market growth.
Hemophilia A Market - A Global and Regional Analysis: Focus on Treatment Type, Country, and Region - Analysis and Forecast, 2025-2035
The global hemophilia A market is highly competitive, with several leading companies driving innovation and market growth.
Need reports on an on-going basis? Do consider our
annual subscription
Dental Soft-tissue Regeneration Market - A Global and Regional Analysis: Focus on Product Type, Application, End User, Country, and Region- Analysis and Forecast, 2025-2035
The global Dental Soft-Tissue Regeneration market is indeed highly competitive, with numerous prominent players shaping the industry's growth and innovation.
Hepatorenal Syndrome Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035
The Hepatorenal Syndrome Market was valued at $1.7 billion in 2023, driven by rising liver disease complications and growing adoption of HRS-AKI and HRS-CKD therapies.
Asia-Pacific Interventional Ultrasound Market: Focus on Application, End User, and Country - Analysis and Forecast, 2025-2035
The Asia-Pacific interventional ultrasound market is projected to reach $1,237.5 million by 2035 from $590.9 million in 2024, growing at a CAGR of 7.06% during the forecast period 2025-2035.
Knee Replacement Surgery Market - A Global and Regional Analysis: Focus on Procedure Type, Product Type, Application, End User, Country, and Region - Analysis and Forecast, 2025-2035
The global Knee Replacement Surgery market, valued at USD 10.12 billion in 2023, is driven by rising osteoarthritis cases and advances in prosthetic implants.
Oral Rinses Market - A Global and Regional Analysis: Focus on Indication, Product Type, Distribution Channel, Country, and Region - Analysis and Forecast, 2025-2035
The global oral rinses market is highly competitive, with major players driving market growth through continuous innovation.
The Common Warts market is expected to continue expanding as new solutions and better patient accessibility are introduced.
The global portal hypertension drugs market is driven by several key factors that are reshaping the landscape of diagnosis, treatment, and patient care.
Agitation in Alzheimer’s Disease refers to a set of symptoms characterized by increased aggression, and emotional instability in patients suffering from Alzheimer's disease.
The global acute bacterial skin and skin structure infection market is growing due to rising infection prevalence, influenced by changing lifestyles and environmental factors.
The global myelofibrosis market grows with advances in JAK inhibitors, improving symptom management, treatment outcomes, and patient quality of life.
Nasal Polyposis are soft, painless, noncancerous growths that develop in the lining of the nose and sinuses, often appearing in clusters and shaped like teardrops.
The global Mucopolysaccharidosis market is fueled by rising demand for effective therapies to manage glycosaminoglycan buildup, prevent organ damage, and improve lives.
EGFR non-small cell lung cancer is caused by mutations in the EGFR gene, leading to uncontrolled cancer cell growth.
Fanconi Anemia is a rare, inherited genetic disorder that primarily affects the bone marrow, leading to a failure in producing adequate blood cells, a condition known as pancytopenia.
Idiopathic pulmonary fibrosis is a progressive lung disease characterized by the gradual scarring (fibrosis) of lung tissue, which impairs the ability of the lungs to function properly.
Liver fibrosis is a progressive disease where scar tissue builds up in the liver due to chronic damage from hepatitis, alcohol use, obesity, or autoimmune conditions.
Coronary microvascular dysfunction (CMD) affects the heart’s small vessels, reducing blood flow and oxygen supply, often occurring without obstructive coronary artery disease.
The cytomegalovirus infection market is driven by the increasing prevalence of CMV infections, especially in high-risk populations such as organ transplant recipients, individuals with HIV/AIDS, and pregnant women.
Facioscapulohumeral muscular dystrophy is a genetic disorder characterized by progressive muscle weakness and degeneration.
The global HSPC market is growing, fueled by rising prostate cancer cases, advances in hormonal and combo therapies, and growing focus on precision medicine.
The global Dupuytren's disease market is fuelled by rising prevalence, aging populations, increased awareness, and enhanced diagnostic capabilities worldwide.
Dermatomyositis, a rare inflammatory myopathy marked by skin issues and muscle weakness, is gaining recognition globally, driving demand for effective treatment options.
The global familial chylomicronemia syndrome (FCS) market is growing steadily, driven by rising disease awareness, advanced genetic diagnostics, and innovative therapies.
The Pompe disease market is driven by advancements in enzyme replacement therapies, improved diagnostic technologies, & a better understanding of the disease’s pathophysiology.
The Europe flow cytometry market is projected to reach $2,045.7 million by 2035 from $928.3 million in 2024, growing at a CAGR of 7.53% during the forecast period 2025-2035.
The global psoriasis market is driven by innovations in treatment options, increased awareness of dermatological conditions, and the rising prevalence of autoimmune disorders.
The Europe robotic neurosurgery market is projected to reach $585.3 million by 2035 and estimated $93.1 million in 2024, growing at a CAGR of 17.83% during the forecast period 2025-2035.
The Asia-Pacific flow cytometry market, valued at $747.7 million in 2024, is on a robust growth trajectory and is anticipated to reach $1,919.6 million by 2035.
LEMS is a rare autoimmune neuromuscular disorder characterized by muscle weakness and autonomic dysfunction, caused by impaired communication between nerves and muscles.
The cytokine release syndrome market is growing, driven by rising prevalence and increasing use of immunotherapies like CAR T-cell therapies and checkpoint inhibitors.
The global VLU market is expanding, driven by rising chronic conditions, growing awareness, and advancements in wound care technologies.
The ITP market is undergoing steady transformation, driven by increasing disease awareness, innovations in targeted therapies, and a growing emphasis on individualized care strategies.
This growth is primarily driven by the increased awareness of this rare and aggressive soft tissue cancer, primarily affecting adolescents and young adults.
The global ventricular hypertrophy market is driven by the increasing prevalence of cardiovascular diseases, heightened awareness of VH, and advancements in diagnostic and treatment options.
The hunter syndrome market is primarily driven by the rising diagnosis rates, which have been facilitated by advancements in diagnostic technologies such as genetic testing and enzyme activity assays.
Barrett’s esophagus, caused by chronic acid reflux, leads to abnormal esophageal cell changes and mainly affects middle-aged men, obese individuals, and long-term GERD patients.
The global CAR T-Cell therapy for non-hodgkin’s lymphoma market is driven by a convergence of clinical innovation, rising disease prevalence, and the unmet need for durable treatments in relapsed or refractory cases.
Dyslipidemia, characterized by abnormal levels of lipids such as cholesterol and triglycerides in the blood, significantly elevates the risk of cardiovascular diseases.
The global dystrophic epidermolysis bullosa market is driven by rising awareness, advances in early diagnosis, and improved treatment options.
The global tardive dyskinesia (TD) market is set for steady growth, driven by advancements in novel therapeutics, increasing clinical awareness, and early diagnosis among psychiatric populations.
Growth is driven by rising prevalence, awareness, better diagnostics, and expanding mental health infrastructure, especially in well-equipped regions.
Autism spectrum disorder (ASD) encompasses a broad range of neurodevelopmental conditions characterized by challenges in social interaction, communication, and repetitive behaviours.
The global bullous pemphigoid market is driven by an increase in the global prevalence of the disease, coupled with advancements in early diagnosis, improved healthcare infrastructure, and a greater awareness of autoimmune skin disorders.
The systemic mastocytosis market is driven by the increasing prevalence of KIT gene mutations, enhanced disease awareness, and substantial advancements in targeted therapy and molecular diagnostics.
The global adrenoleukodystrophy market is driven by rising awareness and advancements in gene therapy and innovative drug treatments for better outcomes.
The global cholestatic pruritus market is growing due to rising liver disease cases, increased awareness, and advances in pharmacological and non-drug therapies.
The global spondylolisthesis market is growing due to rising spine disease cases, better awareness, and advances in surgical and non-surgical treatments.
The global cancer cachexia market grows steadily due to rising cancer cases and increased awareness of cachexia as a serious cancer-related complication.
The chronic hand eczema market grows due to rising occupational skin issues, greater dermatology awareness, and advanced treatment options.
The functional dyspepsia market is driven by increased disease awareness, improved diagnostic methods, and advancements in personalized medicine and treatment strategies.
Niemann-Pick Disease Type C (NPC) is a rare and progressive genetic disorder caused by mutations in the NPC1 or NPC2 genes, which are responsible for lipid transport within cells.
Tenosynovitis is an inflammation of the tendon sheath, the protective covering surrounding the tendons in the body.
The global cancer pain market is fuelled by the rising prevalence of cancer cases globally and the increasing demand for effective pain management therapies.
The global cancer vaccine market is witnessing significant growth due to rising cancer prevalence, increasing adoption of immunotherapies, and advancements in vaccine development technologies
Leptomeningeal metastases refer to the spread of cancer cells to the leptomeninges—the two innermost layers of tissue covering the brain and spinal cord—and the cerebrospinal fluid.
Leigh syndrome is a rare and severe neurological disorder that primarily affects infants and young children.
Historically, Morquio Syndrome (MPS IV) has been underdiagnosed due to its rarity and symptom overlap with other skeletal disorders.
The Lennox gastaut syndrome market is experiencing significant growth due to the increasing prevalence of the condition, advancements in drug therapies, and the rising recognition of the need for better management options.
The global candidemia market is witnessing significant growth, driven by the rising incidence of candidemia infections and the increasing focus on antifungal drug development.
In HER2-positive gastric cancer, the overexpression of HER2 leads to aggressive tumor growth and metastasis.
The global chronic hepatitis B market is currently in the growth stage, driven by significant advancements in the diagnosis and treatment of the disease.
22q11.2 deletion syndrome, also known as DiGeorge syndrome or velocardiofacial syndrome, is a genetic disorder caused by the deletion of a small segment of chromosome 22.
The global allergic rhinitis market is set to grow due to rising allergy cases, advanced treatments, and increasing awareness of effective management.
Growth is driven by rising vasculitis cases, advances in biologics and immunosuppressants, and demand for better treatment outcomes.
The global ultrasensitive molecular amplification market is witnessing significant growth, driven by advancements in diagnostic technologies, rising prevalence of infectious and genetic disorders, and increasing demand for early and precise detection methods.
The global sickle cell disease treatment market is set to grow, driven by rising disease prevalence and demand for effective, accessible therapies.
Stargardt disease, also referred to as Stargardt's macular dystrophy or juvenile macular degeneration is the most prevalent form of macular degeneration in young individuals.
Non-Cystic fibrosis bronchiectasis (NCFB) is a chronic lung condition characterized by the permanent widening and scarring of the bronchi, the airways in the lungs.
The global acute on chronic liver failure market is driven by the rising prevalence of liver diseases like cirrhosis and chronic hepatitis, which are the primary causes of acute on chronic liver failure.
Key factors driving this market include the increasing incidence of brain cancer, advancements in medical technology, and the growing focus on personalized medicine.
The Brazil airway management devices market is set to experience significant growth due to the increasing demand for advanced airway management solutions driven by the rising prevalence of respiratory disorders and the growing need for surgical procedures requiring precise airway management.
The global anaesthesia devices market is expected to experience significant growth, driven by the increasing demand for advanced anaesthesia devices across various medical specialities, such as neurology, orthopaedics, and cardiology.
Laser interstitial thermal therapy is an emerging minimally invasive neurosurgical technique that uses focused laser energy to thermally ablate pathological tissues.
The global alagille syndrome market is expected to grow at a significant rate due to developments in targeted therapies, rising awareness and diagnosis, and a growing clinical pipeline, alongside advancements in healthcare infrastructure and access to specialized treatments.
The Messenger RNA Market growth is supported by significant investments from both public and private sectors, accelerating research and development in mRNA technology.
The market for Adult T-cell leukemia/Lymphoma is growing with increased adoption of immunotherapies like CAR-T cell therapies, alongside chemotherapy and stem cell transplants.
The global gene therapy in ophthalmology market is on track for continued growth, driven by the aging population, rising prevalence of genetic ocular disorders, and technological advancements in gene editing and delivery.
The Diabetic Peripheral Neuropathy (DPN) treatment market is experiencing rapid transformation, fueled by advancements in pharmacological therapies, medical devices, and emerging treatment innovations.
The Aicardi-Goutières syndrome market is in early development, with no approved treatments and ongoing research focused on genetics and targeted therapy development.
The High-Grade Glioma market is witnessing transformative trends fueled by advancements in personalized medicine, immunotherapy, and targeted therapies.
The Australia and New Zealand arthroscopy market is set to experience substantial growth due to increasing demand for minimally invasive surgeries and advancements in arthroscopy technologies.
The global epilepsy drugs market is driven by the increasing prevalence of epilepsy, ongoing advancements in drug development, and heightened awareness of neurological disorders.
The global acute lymphocytic leukemia market is driven by advancements in treatment options, particularly in chemotherapy, targeted therapies, and immunotherapy.
The global oncology liquid biopsy market is experiencing significant growth, driven by the increasing prevalence of various cancers such as breast, prostate, lung, and colorectal cancer.
The atrial fibrillation (AF) market is experiencing significant growth, driven by the rising prevalence of the condition, increasing awareness, and advancements in treatment options.
The U.S. Cervical cancer laboratory testing maket refers to diagnostic procedures used to detect abnormalities in the cervix that may lead to cervical cancer.
Genetic screening testing for preventive health market involves analyzing an individual’s genetic makeup to predict the likelihood of developing certain diseases or conditions in the future.
Genetic screening testing for reproductive health refers to a set of medical tests designed to assess the genetic makeup of individuals before or during pregnancy.
The Point-of-Care (PoC) Cell and Gene Therapy Manufacturing Market is projected to grow significantly driven by key advancements in automation, decentralized manufacturing, and personalized medicine.
The north america immunoassay market is driven by advancements in healthcare, increasing disease prevalence, and a shift toward precision diagnostics.
The in-vitro diagnostics (IVD) market in North America is growing due to rising chronic diseases, technological advancements, and a shift toward personalized medicine.
This report provides an in-depth market analysis, covering segmentation by application, technology, product, end-user, and geography.
The global market for CRISPR gene diagnostics is growing robustly. In 2025, the market size is projected around USD 3 billion, and it is expected to double to approximately USD 7 billion by 2030.
Pain management devices include a range of technologies designed to alleviate chronic, acute, and post-surgical pain.
Softgel capsules are a preferred dosage form for liquid or semi-solid substances, offering several benefits including ease of swallowing, precise dosing, improved bioavailability, and protection of sensitive ingredients from environmental degradation.
Whole genome sequencing refers to the DNA sequencing of the entire genome, both coding and non-coding regions to detect inherited disease and track disease outbreaks.
Whole-exome sequencing is utilized to examine the protein-coding regions of the genome, aiming to reveal genetic factors that influence disease and population health.
A blood pressure cuff is a medical device used to measure blood pressure. The cuff is placed around the upper arm and inflated to temporarily halt blood flow in the artery.
The global specialty excipients for parenteral pharmaceuticals market is witnessing significant growth, driven by increasing demand for advanced drug delivery systems, particularly for biologics and complex formulations.
The empty capsules are primarily used for encapsulating powdered and granular substances. These capsules, typically made from gelatin or vegetable-based materials, offer an effective delivery system for medications, vitamins, and other supplements.
The global excipients market for topical pharmaceuticals is growing, driven by demand for effective dermatological treatments and cosmeceuticals.
The liquid-filled capsules market is rapidly evolving, characterized by the growing preference for innovative delivery systems in the pharmaceutical and nutraceutical sectors.
The Hybrid Medicine market is quickly gaining traction as healthcare providers increasingly look to combine conventional treatments with alternative therapies for more comprehensive patient care.
The Cell Line Characterization Market Report provides a comprehensive analysis of the global market, offering valuable insights into the trends, and future prospects of the industry.
The global 3D image capture in wound care market report provides a comprehensive analysis of the industry, offering insights into key market trends, growth drivers, challenges, and opportunities within the wound care sector.
The global next-generation contraceptives market report provides a comprehensive analysis of the industry, offering insights into key market trends, growth drivers, challenges, and opportunities, and forecasts that a decision-maker can take advantage of.
The global shadowless surgical lights market report provides a comprehensive analysis of the industry, offering insights into key market trends, growth drivers, challenges, and opportunities within the surgical lighting sector.
This comprehensive report provides an in-depth analysis of the global implantable microchip market. It offers a detailed examination of the market dynamics, including drivers, restraints, opportunities, and challenges that influence the growth trajectory of the industry.
The global ultrasound systems market report provides a comprehensive analysis of the industry, offering insights into market dynamics, trends, and growth prospects.
The global SPECT market report provides a comprehensive analysis of the industry, highlighting key trends, market dynamics, and growth opportunities.
The Antibody Hit Generation and Screening Market report covers key segments, competitive landscape, and emerging technologies, offering stakeholders a holistic view of the global market.
Explore the Global Dialysis Equipment Market, driven by rising kidney disease rates & technological advancements, offering improved patient care and treatment efficiency.
Cardiac marker tests offer valuable information to healthcare providers, facilitating rapid diagnosis and risk stratification of cardiac events.
Incubator Systems Market explores market based on segmentations such as by technology, by end user, and by product type, the impact of macroeconomic factors market growth
The healthcare robotics market has undergone a gradual, however, considerable development over the last few decades.
The global clinical biomarkers market was valued at $24.80 billion in 2023 and is expected to reach $53.20 billion by 2033, growing at a CAGR of 7.93% between 2023 and 2033.
The global digital therapeutics market is projected to reach $46.80 billion by 2033 from $4.90 billion in 2022, growing at a CAGR of 22.93% during the forecast period 2023-2033.
The market is expected to grow at a CAGR of 15.43% during the forecast period 2023-2032 and attain a value of $80.05 billion by 2032.
The market is expected to grow at a CAGR of 11.31% during the forecast period 2023-2033 and attain a value of $36.82 billion by 2033.
The global genomic cancer panel and profiling market is expected to reach $26.59 billion by 2033 from $9.90 billion in 2022.
In 2022, the India emerging infectious disease diagnostics market was valued at $339.1 million and is expected to grow at a CAGR of 10.29% during the forecast period 2023-2033 to register a value of $982.7 million in 2033.
The global scar management market was valued at $1,040.1 million in 2022 and is anticipated to reach $1,594.4 million by 2030, witnessing a CAGR of 5.53% during the forecast period 2023-2030.
The global wound cleanser market was valued at $1,873.4 million in 2022 and is expected to reach $2,434.3 million by 2030, growing at a CAGR of 3.34% between 2023 and 2030.
The global gene fusion testing market was valued at $255.3 million in 2022 and is anticipated to reach $897.6 million by 2033, witnessing a CAGR of 12.25% during the forecast period 2023-2033.
The global rare disease genetic testing market was valued at $4.11 billion in 2022 and is anticipated to reach $16.69 billion by 2033, witnessing a CAGR of 13.69% during the forecast period 2023-2033.
The global cell free DNA isolation and extraction market was valued at $81.7 million in 2016, and is anticipated to reach $442.8 million by 2026.
Overall in 2017 the global minimally invasive surgical systems market value was estimated at $23.95 billion, which is estimated to grow over $40.52 billion by 2025.
The total addressable market size for laparoscopic and endoscopic devices market was $17.78 billion in the year 2016 and is expected to reach about $27.92 billion by the end of 2025.
The global liquid biopsy market is anticipated to reach $2.94 billion by 2028, witnessing a CAGR of 14.45% in the forecast period 2018-2028.
The global CDx market is expected to continue to grow with a double digit CAGR of 21.38% during the forecast period, 2018-2025.
The global rare disease diagnostics market was valued $45.18 billion in 2017 and is anticipated to reach $86.15 billion by 2025.
The global surgical robotics market is expected to reach $11.65 billion by 2025. The market consists of various product segments such as surgical systems, instruments and accessories and maintenance services.
The global recombinant cell culture supplements market was valued $230.5 million in 2017 and is anticipated to reach $788.6 million by 2028.
The global molecular diagnostics market has been witnessing a steady growth since the end of the Human Genome Project in 2003. The market is expected to continue to grow with a double digit CAGR of 10.89% during the forecast period, 2018-2028.
The global precision medicine market is anticipated to reach $216.75 billion by 2028, witnessing a CAGR of 10.64% in the forecast period 2018-2028.
The global industrial microbiological QC market is expected to continue to grow with a single digit CAGR of 6.22% during the forecast period, 2019-2028.
The global OR integration systems market is expected to continue to grow with a single digit CAGR of 7.1% during the forecast period, 2019-2025.
The global direct-to-consumer market was valued at approximately $824.1 million in 2018 and is anticipated to reach $6,364.5 million by 2028.
The global pharmacogenomics market has been witnessing a steady growth since the end of the Human Genome Project in 2003. The market is expected to continue to grow with a double digit CAGR of 6.98% during the forecast period, 2019-2028.
The global single cell multi-omics industry analysis by BIS Research projects that the market was valued at $1.83 billion in 2018 and is anticipated to generate a value of $5.32 billion by 2025.
The global digital respiratory devices market was valued at approximately $8.5 million in 2018 and is anticipated to reach $334.0 million by 2029.
The global carrier screening market was valued at $846.9 million in 2018 and is estimated to grow over $2.93 billion by 2029.
The Global Clinical Decision Support Systems Market Report by BIS Research projects the market to grow at a significant CAGR of 8.3% during the forecast period from 2019 to 2028.
The cell and gene therapy Industry analysis by BIS Research projects the market to grow at a significant CAGR of 36.52% during the forecast period, 2019-2025.
The AI-enabled medical imaging solutions market to grow at a significant CAGR of 30.95% during the forecast period, 2019-2029.
The Global Operating Room Management Solutions Market Report by BIS Research projects the market to grow at a significant CAGR of 6.4% during the forecast period from 2019 to 2029.
The global robotic surgical simulation systems market was valued to be $276.5 million in the year 2018 and is anticipated to witness an impressive double-digit growth rate, to reach $1.03Â Billion by 2024.
The global surgical robotics market is anticipated to grow at a robust CAGR of 10.7% during the forecast period 2019-2029.
The NGS sample preparation industry analysis by BIS Research projects the market to grow at a significant CAGR of 15.54% during the forecast period, 2019-2025.
Interventional Oncology Devices Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 9.0% during the forecast period 2019-2025.
The hematologic malignancies testing industry analysis by BIS Research projects the market to grow at a significant CAGR of 15.24% during the forecast period, 2019-2025.
The global recombinant cell culture supplements market to grow at a significant CAGR of 12.93% during the forecast period, 2019-2029.
The global neoantigen cancer vaccine market to grow at a significant CAGR of 34.69% during the forecast period, 2023-2030.
The in-silico drug discovery industry analysis by BIS Research projects the market to grow at a significant CAGR of 12.92% during the forecast period, 2019-2029.
The Global Robotic Surgery Consumables Market Report by BIS Research projects the market to grow at a significant CAGR of 11.37% during the forecast period, 2020-2030.
The Global Minimally Invasive Surgical Systems Market Report by BIS Research projects the market to grow at a significant CAGR of 6.51% during the forecast period, 2020-2030.
The Global Next-Generation Biomanufacturing Market Report by BIS Research projects the market to grow at a significant CAGR of 10% during the forecast period, 2019-2029.
The global ENT devices market was valued at $13,799.5 million in 2020 and is projected to reach $25,127.7 million by 2030.
The nucleic acid isolation and purification industry analysis by BIS Research projects the market to grow at a significant CAGR of 5.98% during the forecast period, 2020-2029.
Global clinical biomarkers market analysis by BIS Research projects the market to grow at a significant CAGR of 10.07% during the forecast period, 2019-2029.
The global market for whole genome and exome sequencing is predicted to grow at a CAGR of 26.94% over the forecast period of 2019-2029.
The U.S. solid tumor testing market is projected to reach $15,396.4 million by 2030 from $8,179.7 million in 2019, at a CAGR of 5.91% during the forecast period 2020-2030.
The global companion diagnostics market to grow at a significant CAGR of 12.45% during the forecast period, 2020-2030.
As of 2019, the global Femtech market was estimated to be $820.6 million and is anticipated to grow with a double digit CAGR of 12.65% during the forecast period.
The global market for hereditary genetic testing is predicted to grow at a CAGR of 13.59% over the forecast period of 2020-2030.
The market is predicted to grow at a CAGR of 13.12% over the forecast period of 2020-2030.
The global market for digital PCR (d-PCR) is predicted to grow at a CAGR of 17.57% over the forecast period of 2020-2025.
The global precision medicine market is expected to reach $278.61 billion by the end of 2030. The market is projected to grow at a CAGR of 11.13% during the forecast period, 2020-2030.
By volume, global NIPT market was 3.14 million units in 2019 and is expected to reach 23.58 million units by 2030.
The global liquid biopsy market is projected to reach $12,933 million by 2030 from $2588.6 million in 2019, at a CAGR of 15.87% during the forecast period 2020-2030.
The global digital surgery technologies market was valued at $252.5 million in 2019 and is anticipated to reach $5,110.5 million by 2030, growing at a CAGR of 32.1% during the forecast period 2020-2030.
The spatial genomics and transcriptomics market to be one of the most rapidly evolving markets, which is predicted to grow at a CAGR of 23.20% during the forecast period of 2020-2030.
The global oncology precision medicine market was valued at $46.90 billion in 2019, and it is expected to grow at an impressive double-digit rate of 11.21% and reach a value of $148.66 billion in 2030.
The global market for MRD testing is predicted to grow at a CAGR of 15.64% over the forecast period of 2020-2025.
The global market for microbiome therapeutics is predicted to grow at a CAGR of 25.64% over the forecast period of 2020-2030.
The global AI-enabled medical imaging solutions market was valued at $636.1 million in 2019 and is anticipated to reach $10,145.1 million by 2030, growing at a CAGR of 26.69%, during the forecast period 2020-2030.
The radiation dose management market is expected to grow at a CAGR of 10.96% during the forecast period, 2021-2030.
The global single-cell multi-omics market is projected to reach $3,188.9 million by 2025 from $1,221.5 million in 2020, at a CAGR of 21.16% during the forecast period, 2020-2025.
The global rare disease diagnostics market has been currently witnessing a rapid growth and is expected to continue to grow at a CAGR of 8.57% during the forecast period, 2020-2030.
The market for surgical robotics generated $5.46 billion in 2020, in terms of value and is estimated to reach $16.77 billion by 2031.
The global market for flow cytometry in oncology is predicted to grow at a CAGR of 12.02% over the forecast period 2021-2031.
The global AI in operating room market was valued at $67.8 million in 2020 and is anticipated to reach $2,951.5 million by the end of 2030.
The global minimally invasive surgical systems market is estimated to be valued at $27,882.8 million in 2020 and is anticipated to reach $55,716.7 million by the end of 2031, growing at a CAGR of 6.3% during 2021-2031.
The global nucleic acid therapeutics CDMO market was valued at $1,546.4 million in FY2020 and is estimated to reach $4,463.7 million by 2030.
The global organ transplant diagnostics market is projected to reach $9,663.0 million by 2031, growing from $3,100.3 million in 2020, at a CAGR of 10.92% during the forecast period 2021-2031.
The global constrained peptide drugs market is anticipated to be valued at $60.1 million in 2023 and is expected to reach $10,367.2 million by 2031, witnessing a CAGR of 90.37% during the forecast period 2023-2031.
The global NIPT market was valued at $2.52 billion in 2020 and is expected to reach $12.61 billion by 2031, registering a CAGR of 15.79% during the forecast period 2021-2031.
The global cell-free DNA isolation and extraction market was valued at $169.9 million in 2020 and is expected to reach $735.1 million by 2031, witnessing a CAGR of 14.19% during the forecast period 2021-2031.
The global digital therapeutics market is projected to reach $46.80 billion by 2033 from $4.90 billion in 2022, growing at a CAGR of 22.93% during the forecast period 2023-2033.
The global liquid biopsy market is projected to reach $19,066.0 million by 2032 from $2,508.2 million in 2021 at a CAGR of 19.83% during the forecast period 2022-2032.
The minimal residual disease (MRD) testing market is projected to reach $2,611.2 million by 2027 from $1,089.3 million in 2021, at a CAGR of 14.53%.
The global hematologic malignancies testing market is projected to reach $11,680.1 million by 2032, growing from $2,606.5 million in 2021, at a CAGR of 14.23% during the forecast period 2022-2032.
The global ligase market is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032.
In 2021, the global clinical biomarkers market was valued at $21,304.3 million, and it is expected to reach $54,294.0 million by 2032, growing at a CAGR of 8.73% during the forecast period 2022-2032.
The global digital PCR market is projected to reach $2,847.8 million by 2032 from $441.2 million in 2021, at a CAGR of 18.73% during the forecast period 2022-2032.
In 2021, the global 3D protein structure analysis market was valued at $1,017.2 million, and it is expected to reach $2,676.6 million by 2032, growing at a CAGR of 9.32% during the forecast period 2022-2032.
The Canada laparoscopy devices market was valued at $392.1 million in 2021 and is anticipated to reach $865.6 million by 2031, witnessing a CAGR of 7.31% during the forecast period 2022-2031.
The global molecular oncology diagnostics market was valued at $3,620.6 million in 2021 and is anticipated to reach $12,130.5 million by 2032, witnessing a CAGR of 11.43% during the forecast period 2022-2032.
The global radiation dose management market was valued at $212.8 million in 2021 and is anticipated to reach $586.7 million by 2032, witnessing a CAGR of 10.30% during the forecast period 2022-2032.
The global wearable patches market was valued at $8,650.0 million in 2021 and is projected to reach $26,892.7 million by the end of 2031.
The U.S. prostate cancer testing market is anticipated to reach $1,901.6 million in 2030 from $544.1 million in 2021, with a CAGR of 14.7%, during the forecast period 2022-2030.
The global nucleic acid sample preparation market is projected to reach $11,200.5 million by 2032 from $4,213.0 million in 2022, growing at a CAGR of 10.27% during the forecast period 2022-2032.
The global targeted sequencing market is projected to reach $10,976.1 million by 2032 from $3,198.8 million in 2022, growing at a CAGR of 13.12% during the forecast period 2022-2032.
The global medical X-Ray detectors market was valued at $2,167.0 million in 2022 and is anticipated to grow to $3,702.0 million by the end of 2032, at a projected CAGR of 5.50% during the forecast period 2022-2032.
The global cell and gene therapy biomanufacturing market was valued at $12.31 billion in 2022 and is anticipated to reach $29.76 billion by 2031, witnessing a CAGR of 10.31% during the forecast period 2022-2031.
The global surgical robotics market was valued at $8,705.3 million in 2022 and is anticipated to reach $18,410.9 million by 2032, witnessing a CAGR of 7.78% during the forecast period 2022-2032.
The Asia-Pacific and Middle East NGS market was valued at $1,055.6 million in 2022 and is anticipated to reach $2,370.7 million by 2027, witnessing a CAGR of 17.56% during the forecast period 2022-2027.
The global nucleic acid therapeutics CDMO market was valued at $3.88 billion in 2022 and is expected to reach $14.19 billion by 2033, growing at a CAGR of 12.55% during the forecast period 2023-2033.
In 2022, the global organ transplant diagnostics market was valued at $4.03 billion and is expected to reach $11.78 billion by 2033, with a CAGR of 10.45% during the forecast period 2023-2033.
The global colorectal cancer screening and diagnostic market was valued at $15.28 billion in 2022 and is expected to reach $28.52 billion by 2033, growing at a CAGR of 5.93% during the forecast period 2023-2033.
The global contrast media agent and injector system market was valued at $7,634.6 million in 2022 and is expected to reach $9,712.3 million by 2026, growing at a CAGR of 6.20% during the forecast period 2022-2026.
The global MRD testing market is projected to reach $6.67 billion by 2033 from $1.47 billion in 2022, growing at a CAGR of 14.81% during the forecast period 2023-2033.
The global gene fusion testing market was valued at $255.3 million in 2022 and is anticipated to reach $897.6 million by 2033, witnessing a CAGR of 12.25% during the forecast period 2023-2033.
The global rare disease genetic testing market was valued at $4.11 billion in 2022 and is anticipated to reach $16.69 billion by 2033, witnessing a CAGR of 13.69% during the forecast period 2023-2033.
The global wound cleanser market was valued at $1,873.4 million in 2022 and is expected to reach $2,434.3 million by 2030, growing at a CAGR of 3.34% between 2023 and 2030.
The global scar management market was valued at $1,040.1 million in 2022 and is anticipated to reach $1,594.4 million by 2030, witnessing a CAGR of 5.53% during the forecast period 2023-2030.
In 2022, the India emerging infectious disease diagnostics market was valued at $339.1 million and is expected to grow at a CAGR of 10.29% during the forecast period 2023-2033 to register a value of $982.7 million in 2033.
The market is expected to grow at a CAGR of 15.43% during the forecast period 2023-2032 and attain a value of $80.05 billion by 2032.
The global genomic cancer panel and profiling market is expected to reach $26.59 billion by 2033 from $9.90 billion in 2022.
The market is expected to grow at a CAGR of 11.31% during the forecast period 2023-2033 and attain a value of $36.82 billion by 2033.
The global clinical biomarkers market was valued at $24.80 billion in 2023 and is expected to reach $53.20 billion by 2033, growing at a CAGR of 7.93% between 2023 and 2033.
I would like to extend our appreciation for your support in finalizing the report according to our precise needs and prerequisites. I am also impressed by the timely completion of all aspects of dealing with us as your esteemed client. I look forward to continue our professional relations in the future.
Manager-Strategy & Business DevelopmentICL Industrial Products
“I found the content quite interesting and insightful. It has provided us with some important information”
Strategic Insights COE ManagerJapan Tobacco International
I appreciate the extra effort that team BIS took to cater to our specific requirements, moreover, their response time and adaptability is at par with my expectation.
CEO & ChairmanTEKNA Plasma Systems
“BIS research has been a great support to our strategic investigation in the field of thermoplastic composite. BIS did manage to bring together a clear picture on a global level, supported by examples and references and they delivered an accurate evaluation of the current market size and potential in the coming years in line with our expectations. I warmly recommend them.”
VPFuture Business and Innovation
Trusted by the world's largest business
